Article Details

Biopharma to Test Immunity Activator in Advanced Solid Cancers

Retrieved on: 2019-12-17 08:00:00

Tags for this article:

Click the tags to see associated articles and topics

Biopharma to Test Immunity Activator in Advanced Solid Cancers. View article details on hiswai:

Excerpt

<div>As of November 30, 2019 neither the Firm nor its affiliates beneficially own 1% or more of any class of common <b>equity securities</b> of BioXcel ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up